Underweight LRCX with 25% trim, $256 stop, $309 re-engage trigger, Q1 FY27 AR normalization as binary cycle tell
Underweight LRCX with 25% trim capturing ~4-5% of NAV in cash while preserving 75% core participation in AI capex thesis through HBM3E/GAA/HBM4 ramps. Stop at $256 (12% max drawdown from current) honors 8/26 binding reflection on compressing stops toward thesis invalidation. Re-engagement above $309 with volume gives structural bid every chance before capitulation. Q1 FY27 earnings is the binary cycle tell on whether AR/revenue normalization validates AI thesis durability or confirms cycle-peak concerns, with AR growth threshold of 1.5x revenue growth as the monitorable data point separating Hold/Overweight from further Underweight/Sell.
| Position | Action |
|---|---|
| Scale into strength above $295 over 5-10 trading sessions | Trim 25% of LRCX exposure via staged sales |
| Price drops to $256 (below 200 SMA at $258) | Stop out remaining 75% core position |
| Close above $309 (10 EMA) on >9.5M shares | Pause trimming, add back 10% |
| No trade above $295 within 10 sessions | Execute trim at prevailing price |
LRCX's 30% revenue acceleration and 370 bps of margin expansion in Q4 FY26 signal an AI-driven WFE up-cycle inflection, making the current 15% pullback a tactical entry point within a structural bull market led by physical AI infrastructure capex.
| Indicator | Value | Signal |
|---|---|---|
| close | 290.20 | neutral |
| volume | 8,155,813 | neutral |
| 10_ema | 309.21 | bearish |
| 50_sma | 329.22 | bearish |
| 200_sma | 257.77 | bullish |
| rsi | 40.77 | neutral |
| macd | -4.09 | bearish |
| macd_signal | -2.43 | bearish |
| macd_histogram | -1.66 | bearish |
| bollinger_middle | 315.35 | neutral |
| bollinger_upper | 340.80 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price above $295 with strength
Then: Execute 25% trim in staged sales over 5-10 trading sessions
Long-term technical structure remains intact — pullback is tactical, not structural
↩ rebuts: “Bear claims below 10 EMA and 50 SMA means bearish trend”
EV: $315 (Boll mid), $329 (50 SMA), $340 (Boll upper); Risk/reward 2:1 to 4:1 on confirmed bounce
LRCX is being purchased at the worst possible point in its cycle—cyclical peak revenue with late-cycle technical damage, 1.87 beta, growing receivables outpacing revenue, and sell-side estimates at their most optimistic—all while the macro environment threatens to reprice multi-year AI capex payback periods higher.
EV: -$32 to $258 (downside to 200 SMA) · concedes: AI capex is real and physical—demand is tangible, not narrative-driven; Gross margins at 51.8% reflect genuine product strength and pricing power; Long-term debt at $3.72B is manageable in isolation; Oregon lab could prove strategically valuable if AI buildout extends beyond typical WFE cycle; Customer concentration does provide direct exposure to AI capex winners
→ vs conservative: Anchoring on backward-looking Q4 FY26 data (30% revenue growth, 37% margins, near-doubled EPS) while ignoring 58% receivables growth outpacing revenue by nearly 2x — the late-cycle pull-forward and extended payment terms signal the thesis is cracking
→ vs neutral: Technical report's 'cautiously bullish tactical bias' and waiting for confirmation above 309 requires a 6.5% pullback from current levels before acting; lower Bollinger Band pierce is a signal to take risk off, not add
| bollinger_lower | 289.90 | bullish |
| atr | 18.11 | neutral |
| vwma | 317.70 | bearish |
Support: 252.35 · 257.77 · 286.59 · 289.9 | Resistance: 296.34 · 309.21 · 315.35 · 329.22 · 340.8
LRCX technical analysis shows a neutral short-term trend with mixed signals: long-term bullish structure remains intact above the 200 SMA at 257.77, but medium and short-term trends are bearish below the 50 SMA (329.22) and 10 EMA (309.21). The stock pierced the Bollinger lower band at 289.90 with today's intraday low of 286.59, suggesting oversold extension. MACD momentum is bearish but fading (histogram -1.66 narrowing), while RSI at 40.77 sits in neutral territory. VWMA at 317.70 confirms net institutional selling during the pullback. Key resistance at 309.21 (10 EMA) and 315.35 (Bollinger mid), with critical support at 257.77 (200 SMA). Rating: HOLD — await close above 309.21 with MACD bullish cross before initiating longs.
Market Cap
$363.1B
Beta
1.865
Revenue TTM
$23.23B
Gross Profit
$11.73B
Gross Margin
50.5%
EBITDA
$8.64B
Operating Margin
37.4%
Net Income
$7.27B
Diluted EPS
$5.76
Profit Margin
31.3%
Return on Equity (ROE)
65.1%
Return on Assets (ROA)
22.8%
Free Cash Flow
$3.09B
Dividend Yield
0.44%
Q4 FY25 Revenue
$5,171M
Q4 FY25 Gross Margin
50.0%
Q4 FY25 Operating Margin
33.7%
Q4 FY25 Net Income
$1,720M
Q4 FY25 Diluted EPS
$1.35
Q1 FY26 Revenue
$5,324M
Q1 FY26 Gross Margin
50.4%
Q1 FY26 Operating Margin
34.4%
Q1 FY26 Net Income
$1,569M
Q1 FY26 Diluted EPS
$1.24
Q2 FY26 Revenue
$5,345M
Q2 FY26 Gross Margin
49.6%
Q2 FY26 Operating Margin
33.9%
Q2 FY26 Net Income
$1,594M
Q2 FY26 Diluted EPS
$1.26
Q3 FY26 Revenue
$5,841M
Q3 FY26 Gross Margin
49.8%
Q3 FY26 Operating Margin
35.0%
Q3 FY26 Net Income
$1,825M
Q3 FY26 Diluted EPS
$1.45
Q4 FY26 Revenue
$6,722M
Q4 FY26 Gross Margin
51.8%
Q4 FY26 Operating Margin
37.4%
Q4 FY26 Net Income
$2,277M
Q4 FY26 Diluted EPS
$1.81
R&D
$643M
Cash & Equivalents
$5,579M
Accounts Receivable
$5,340M
Inventory
$4,276M
Total Current Assets
$15,611M
Total Assets
$23,530M
Long-Term Debt
$3,722M
Total Liabilities
$11,059M
Stockholders' Equity
$12,471M
Working Capital
$9,673M
Net PPE
$2,956M
Current Ratio
2.63x
Debt/Equity
33.0%
Net Cash Position
$1.86B
TTM Operating Cash Flow
$5.86B
TTM CapEx
$967M
TTM Free Cash Flow
$3.09B
TTM FCF Margin
~13.3%
TTM Dividends
$1.27B
TTM Buybacks
$3.85B
Treasury Stock
$31.60B
TTM PE
50.4x
Forward PE
25.1x
PEG Ratio
1.48
Price/Book
29.1x
52-Week High
$438.50
52-Week Low
$94.11
50-Day MA
$329.46
200-Day MA
$258.05
Forward EPS
$11.57
Q4 YoY EPS Growth
+34.1%
Operating Margin Delta
+370 bps
Strengths
Concerns
Lam Research reported TTM revenue of $23.23B with best-in-class profitability metrics including 37.4% operating margin and 65.1% ROE, demonstrating exceptional capital efficiency. The Q4 FY26 quarter marked a decisive inflection point with +30% YoY revenue growth, 51.8% gross margin (new high), and EPS of $1.81 nearly doubling from the prior year base, signaling a classic WFE up-cycle ramp driven by AI, HBM, and leading-edge logic demand. The company maintains a strong balance sheet with $1.86B net cash, generated $3.09B in free cash flow, and returned $5.1B to shareholders via buybacks and dividends, though the stock trades near 52-week highs with a stretched 50.4x TTM PE against elevated 1.87 beta.
Macro: Fed policy priced for "higher for longer": 89% probability of zero rate cuts in 2026 (up +2.5pp week-over-week on $7.8M Polymarket volume). All scenarios for 6+ cuts at 0%. Rising crude oil and Treasury yields renew inflation/borrowing-cost fears, directly pressuring semi-equipment names. However, LRCX earnings tied to physical AI infrastructure (HBM, advanced logic, advanced packaging) provide partial rate-sensitivity hedge vs. pure software multiples. BofA flagged semis as enhanced buying opportunities despite near-term pressure.